226 related articles for article (PubMed ID: 16368258)
1. Cortical and amygdalar Lewy body burden in Parkinson's disease patients with visual hallucinations.
Papapetropoulos S; McCorquodale DS; Gonzalez J; Jean-Gilles L; Mash DC
Parkinsonism Relat Disord; 2006 May; 12(4):253-6. PubMed ID: 16368258
[TBL] [Abstract][Full Text] [Related]
2. Lewy body densities in the entorhinal and anterior cingulate cortex predict cognitive deficits in Parkinson's disease.
Kövari E; Gold G; Herrmann FR; Canuto A; Hof PR; Bouras C; Giannakopoulos P
Acta Neuropathol; 2003 Jul; 106(1):83-8. PubMed ID: 12687392
[TBL] [Abstract][Full Text] [Related]
3. Nigral and extranigral pathology in Parkinson's disease.
Braak H; Braak E; Yilmazer D; Schultz C; de Vos RA; Jansen EN
J Neural Transm Suppl; 1995; 46():15-31. PubMed ID: 8821039
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein E epsilon4 and catechol-O-methyltransferase alleles in autopsy-proven Parkinson's disease: relationship to dementia and hallucinations.
Camicioli R; Rajput A; Rajput M; Reece C; Payami H; Hao C; Rajput A
Mov Disord; 2005 Aug; 20(8):989-94. PubMed ID: 15852364
[TBL] [Abstract][Full Text] [Related]
5. Regional cortical grey matter loss in Parkinson's disease without dementia is independent from visual hallucinations.
Meppelink AM; de Jong BM; Teune LK; van Laar T
Mov Disord; 2011 Jan; 26(1):142-7. PubMed ID: 20922809
[TBL] [Abstract][Full Text] [Related]
6. Neuropsychological correlates of mild to severe hallucinations in Parkinson's disease.
Llebaria G; Pagonabarraga J; Martínez-Corral M; García-Sánchez C; Pascual-Sedano B; Gironell A; Kulisevsky J
Mov Disord; 2010 Dec; 25(16):2785-91. PubMed ID: 20960483
[TBL] [Abstract][Full Text] [Related]
7. Relationships between age and late progression of Parkinson's disease: a clinico-pathological study.
Kempster PA; O'Sullivan SS; Holton JL; Revesz T; Lees AJ
Brain; 2010 Jun; 133(Pt 6):1755-62. PubMed ID: 20371510
[TBL] [Abstract][Full Text] [Related]
8. Visual object recognition and attention in Parkinson's disease patients with visual hallucinations.
Meppelink AM; Koerts J; Borg M; Leenders KL; van Laar T
Mov Disord; 2008 Oct; 23(13):1906-12. PubMed ID: 18709671
[TBL] [Abstract][Full Text] [Related]
9. Cerebral basis of visual hallucinations in Parkinson's disease: structural and functional MRI studies.
Ibarretxe-Bilbao N; Junque C; Marti MJ; Tolosa E
J Neurol Sci; 2011 Nov; 310(1-2):79-81. PubMed ID: 21705027
[TBL] [Abstract][Full Text] [Related]
10. Attentional and perceptual impairments in Parkinson's disease with visual hallucinations.
Koerts J; Borg MA; Meppelink AM; Leenders KL; van Beilen M; van Laar T
Parkinsonism Relat Disord; 2010 May; 16(4):270-4. PubMed ID: 20153970
[TBL] [Abstract][Full Text] [Related]
11. Topographical distribution of cerebral cortical thinning in patients with mild Parkinson's disease without dementia.
Lyoo CH; Ryu YH; Lee MS
Mov Disord; 2010 Mar; 25(4):496-9. PubMed ID: 20108369
[TBL] [Abstract][Full Text] [Related]
12. Gray matter atrophy in Parkinson disease with dementia and dementia with Lewy bodies.
Beyer MK; Larsen JP; Aarsland D
Neurology; 2007 Aug; 69(8):747-54. PubMed ID: 17709706
[TBL] [Abstract][Full Text] [Related]
13. Cognitive impairment patterns in Parkinson's disease with visual hallucinations.
Ozer F; Meral H; Hanoglu L; Ozturk O; Aydemir T; Cetin S; Atmaca B; Tiras R
J Clin Neurosci; 2007 Aug; 14(8):742-6. PubMed ID: 17544275
[TBL] [Abstract][Full Text] [Related]
14. Testing an aetiological model of visual hallucinations in Parkinson's disease.
Gallagher DA; Parkkinen L; O'Sullivan SS; Spratt A; Shah A; Davey CC; Bremner FD; Revesz T; Williams DR; Lees AJ; Schrag A
Brain; 2011 Nov; 134(Pt 11):3299-309. PubMed ID: 21921019
[TBL] [Abstract][Full Text] [Related]
15. Neocortical changes in Parkinson's disease, revisited.
Sugiyama H; Hainfellner JA; Yoshimura M; Budka H
Clin Neuropathol; 1994; 13(2):55-9. PubMed ID: 8205726
[TBL] [Abstract][Full Text] [Related]
16. Clinical evaluation of Parkinson's disease dementia: association with aging and visual hallucination.
Kitayama M; Wada-Isoe K; Nakaso K; Irizawa Y; Nakashima K
Acta Neurol Scand; 2007 Sep; 116(3):190-5. PubMed ID: 17714333
[TBL] [Abstract][Full Text] [Related]
17. Brain response to complex visual stimuli in Parkinson's patients with hallucinations: a functional magnetic resonance imaging study.
Ramírez-Ruiz B; Martí MJ; Tolosa E; Falcón C; Bargalló N; Valldeoriola F; Junqué C
Mov Disord; 2008 Dec; 23(16):2335-43. PubMed ID: 18785653
[TBL] [Abstract][Full Text] [Related]
18. A clinico-pathological study of subtypes in Parkinson's disease.
Selikhova M; Williams DR; Kempster PA; Holton JL; Revesz T; Lees AJ
Brain; 2009 Nov; 132(Pt 11):2947-57. PubMed ID: 19759203
[TBL] [Abstract][Full Text] [Related]
19. Increased 5-HT2A receptors in the temporal cortex of parkinsonian patients with visual hallucinations.
Huot P; Johnston TH; Darr T; Hazrati LN; Visanji NP; Pires D; Brotchie JM; Fox SH
Mov Disord; 2010 Jul; 25(10):1399-408. PubMed ID: 20629135
[TBL] [Abstract][Full Text] [Related]
20. Clinical correlates of selective pathology in the amygdala of patients with Parkinson's disease.
Harding AJ; Stimson E; Henderson JM; Halliday GM
Brain; 2002 Nov; 125(Pt 11):2431-45. PubMed ID: 12390970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
